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Objectives: Using a new preservation strategy, we investigated the per-
formance of hearts from non–heart-beating donors during an observation
period of 24 hours after orthotopic heart transplantation in a pig model.
Methods: In the control group (n  6) beating donor hearts were har-
vested with Bretschneider’s HTK solution and transplanted orthotopically
without reperfusion modifications. In the non–heart-beating donor group
(n  6) hearts were perfused with leukocyte-depleted blood cardioplegia
after 30 minutes of normothermic ischemia. Blood cardioplegia was
supplemented with a sodium-hydrogen exchange inhibitor and adenosine.
After transplantation, a second controlled reperfusion with blood cardio-
plegia was performed.
Results: Preload recruitable stroke work of the left ventricle 24 hours
after transplantation in the control versus non–heart-beating donor group
was 108%  24% versus 103%  18% of baseline values. Myocardial
blood flow of the left and right ventricle was increased to 146%  32% and 176%
 51% in the control group versus 176%  29% and 194%  27% in the
non–heart-beating donor group. Myocardial oxygen consumption was 11.2  2.1
versus 12.8  2.2 mL/100 g per minute at baseline and 11.6  2.6 versus 13.2 
3.1 mL/100 g per minute after 24 hours (not significant). Histologic examination
with Luxol fast blue staining revealed that 2.6%  4.8% of myocytes in the control
group versus 1.8%  1.9% in the non–heart-beating donor group were damaged
irreversibly.
Conclusions: Recovery of donor hearts from non–heart-beating donors is compa-
rable with recovery of organs harvested from heart-beating donors if the above-
mentioned preservation technique is used. These results could encourage the use of
marginal donor hearts and help to expand the limited donor pool.
Currently, the worldwide decreasing number of heart transplanta-tions resulting from an increasing lack of donor organs remains themajor problem in heart transplantation.1The use of marginal donors could help to expand the donor pool.Furthermore, hearts with prolonged ischemia times (4 hours) andhearts from non–heart-beating donors (NHBDs) could be a source
of additional donor organs. At present, these hearts are usually rejected in consid-
eration of an increased risk of primary graft failure.
Previous studies in the pig model by our group have shown that successful heart
transplantation from NHBDs after 30 minutes of normothermic ischemia is possible
if controlled reperfusion with blood cardioplegia is performed along with some new
reperfusion modalities.2,3 These modalities include leukocyte depletion, supplemen-
tation with the sodium-hydrogen exchange inhibitor HOE 642, and start of reper-
fusion with tepid instead of normothermic blood cardioplegia. Despite encouraging
results in these short-term experiments, cardiac output of the hearts was severely
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impaired, and irreversible myocardial damage could not be
excluded. Therefore further experiments with longer obser-
vation times seemed to be necessary.
The purpose of this study was to evaluate the perfor-
mance of hearts harvested from NHBDs 24 hours after
transplantation in comparison with control hearts. The reg-
istration of pressure-volume loops by using the conductance
catheter method provided a detailed analysis of myocardial
contractility. In addition, measurements of regional myocar-
dial perfusion, metabolic parameters (eg, oxygen consump-
tion), and quantification of myocardial damage by means of
histologic examinations enabled complex assessment of
these hearts.
Further refinements of the myocardial protection strategy
were introduced to minimize ischemia-reperfusion damage.
First, blood cardioplegia was supplemented with adenosine.
Adenosine has potent cardioprotective properties involving
metabolic changes, inhibition of neutrophils, and relaxation
of vasculature.4 Second, controlled reperfusions with blood
cardioplegia were performed after completion of each anas-
tomosis to reduce ischemic damage during implantation of
the donor heart.
Materials and Methods
Animals and Anesthesia
All procedures were performed in conformity with the “Guide for
the Care and Use of Laboratory Animals” and the German “Law
on the Protection of Animals.” Pigs of the German Landrace
weighing 34.5  5.0 kg were premedicated with an intramuscular
injection of 0.2 mg/kg flunitrazepam and 7 mg/kg ketamine hy-
drochloride. An ear vein was cannulated, and anesthesia was
induced with 0.1 mg/kg flunitrazepam and 10 mg/kg ketamine
hydrochloride by means of titrated intravenous injection. An en-
dotracheal tube was inserted, and mechanical ventilation was be-
gun. Catheters were introduced into the carotid artery and internal
jugular vein to measure arterial pressure, central venous pressure,
pulmonary artery pressure, and cardiac output.
Surgical Procedure
After median sternotomy, 500 IE/kg heparin was given to all pigs.
A 7F polyurethane catheter was inserted into the left atrium
through the left atrial appendage to monitor left atrial pressure. A
12-gauge cannula was placed into the ascending aorta of the donor
hearts for application of cardioplegia. This cannula was also used
for exsanguination of the animals. After procurement, the donor
hearts were stored in ice-cold cardioplegic solution.
Cardiopulmonary bypass. The heart-lung machine (Sto¨ckert,
Munich, Germany) was filled with a priming of 1000 mL of
hydroxyethyl starch. We used a pediatric oxygenator (D705;
Dideco, Mirandola, Italy), systemic heater-cooler (Jostra, Hirrlin-
gen, Germany), and arterial filter (D733, Dideco). Cannulation of
the ascending aorta was performed by using a 16F aortic cannula.
Cannulation of the superior and inferior venae cavae was achieved
through the right atrium with 20F and 28F cannulas. A 9F vent
catheter was inserted into the left atrium to avoid distention of the
left ventricle. The blood flow was 2.2 to 2.5 L/min.
Orthotopic heart transplantation. Transplantation was per-
formed in a biatrial technique. The left azygos vein, a special
feature of the porcine anatomy, was dissected in the donor. Left
azygos vein and the coronary sinus of the recipient remained
intact. A small catheter was placed in the coronary sinus of the
donor heart to obtain blood samples for metabolic investigations.
At the end of the experiment, the animals were killed by means
of an intravenous injection of potassium chloride.
Control group (n  6). Hearts were harvested in a clinically
comparable manner. Cardiac arrest was induced by 1500 mL of
Bretschneider’s HTK solution (Custodiol; Dr Franz Ko¨hler, Che-
mie GmbH, Alsbach-Ha¨hnlein, Germany; 4°C; perfusion pressure
40-50 mm Hg) applied through the aortic root. The hearts were
stored for 3 hours in ice-cooled HTK solution and transplanted
orthotopically. No reperfusion modifications were used in this
group.
NHBD group (n  6). Circulatory arrest was induced by
means of exsanguination. After zero blood pressure, the animals
were left undisturbed for 30 minutes. The hearts were beating
empty, heart frequency decreased continuously, and complete car-
diac arrest was observed 8 to 12 minutes after zero blood pressure.
Thereafter, controlled reperfusion with 1000 mL of blood car-
dioplegia (blood cardioplegic solution for controlled reperfusion;
Dr Franz Ko¨hler, Chemie GmbH, Germany) was performed
through the aortic root (temperature of 10°C-15°C, perfusion pres-
sure of 40 mm Hg). Blood cardioplegia was leukocyte depleted
(Pall BC1; Pall GmbH, Dreieich, Germany) and supplemented
with 379 mg/L HOE 642 (Hoechst AG, Frankfurt, Germany) and
100 mg/L adenosine (Sigma-Aldrich). Hearts were excised, stored
in ice-cold blood cardioplegic solution for 3 hours, and trans-
planted orthotopically. During implantation, controlled reperfusion
with 300 mL of leukocyte-depleted blood cardioplegia (20°C at 40
mm Hg) through the aortic root was performed after completion of
each anastomosis. Blood cardioplegia was supplemented with
HOE 642 and adenosine. After completion of the last anastomosis,
controlled reperfusion was continued with leukocyte-depleted
blood for 20 minutes. The temperature of reperfusate was 25°C
initially and was stepwise increased to 37°C after 20 minutes
before the aortic clamp was released. After the start of reperfusion,
adenosine at 140 g  kg1  min1 was administered intrave-
nously for 60 minutes.
In both groups weaning from cardiopulmonary bypass was
attempted 60 minutes after the start of reperfusion. For inotropic
support, 0.1 g  kg1  min1 epinephrine was administered.
Hemodynamic Measurements
Cardiac output was measured by using the thermodilution tech-
nique.
Pressure-volume loops were registered by using the conduc-
tance catheter technique (Leycom CFL 512; CD Leycom, Zoeter-
meer, The Netherlands). A 7F pigtail conductance catheter (elec-
trode spacing of 8 mm; Sentron, Roden, The Netherlands) and a 3F
pressure-tip catheter (Millar, Houston, Tex) were introduced
through apical incisions of the left and right ventricle. Hemody-
namic parameters (dp/dt, end-systolic elastance, and preload re-
cruitable stroke work [PRSW]) were calculated by using Leycom
CFL software.
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Regional Myocardial Blood Flow
Regional myocardial blood flow (RMBF) was measured with
fluorescent microspheres. Through a polyurethane cannula, 1.5 mL
(1.5  106) of fluorescent polystyrene microspheres (diameter of
15 m; fluorescent labels: orange, blue-green, and red; Molecular
Probes, Eugene, Ore) mixed with 8.5 mL of heparinized fresh
blood was injected into the left atrium. The injection was per-
formed over a period of 60 seconds.
A reference blood sample was taken from the ascending aorta.
Aspiration of the reference sample (withdrawal rate, 7.5 mL/min)
was started 15 seconds before application of the microspheres and
was continued for 45 seconds after completion of the injection.
Tissue and blood digestion. From each heart, midventricular
slices were obtained from the left (n  4) and right (n  4)
ventricular wall and from the septum (n  4). The ventricular
samples were divided into a subendocardial and subepicardial
specimen. Each of the 20 samples was weighed (Precision Weigh-
er; Sartorius GmbH, Go¨ttingen, Germany). The mean wet weight
of the tissue samples was 0.9  0.2 g. Processing of FMS was
performed by using the so-called sedimentation technique.5,6
Measurement of fluorescence. Fluorescence was determined
with a luminescence spectrophotometer (Perkin Elmer 650-10LC,
U¨ berlingen, Germany) with an excitation wavelength of 427 to 570
nm and an emission wavelength of 468 to 598 nm.
Calculation of myocardial blood flow. The fluorescent signal
in the solution is directly proportional to the number of micro-
spheres present in the sample. Flow to each tissue piece was
calculated by using the following formula:
Qx  (Flux/Fluref)  Qref., (1)
where Qx is defined as blood flow in the tissue sample (in milli-
liters per gram times minutes), Qref is defined as the withdrawal
rate of the reference blood sample (in milliliters per minute), Flux
is defined as fluorescence intensity in the tissue sample (in units
per milliliter), and Fluref is defined as fluorescence intensity in the
reference blood sample (in units per milliliter).
Metabolic Parameters
Blood samples were obtained from the arterial blood, blood car-
dioplegia, and coronary sinus to measure blood gases and glucose
and lactate concentrations (ABL System 625/AS 117; Radiometer
Medical, Copenhagen, Denmark).
Myocardial oxygen consumption was calculated by using the
following equation:
MVO2  (AV) MBF, (2)
where MVO2 is defined as myocardial oxygen consumption (in
milliliters per 100 grams per minute), A is defined as arterial
oxygen concentration (milliliters of oxygen per milliliter of blood),
V is defined as coronary sinus oxygen concentration (in milliliters
of oxygen per milliliter of blood), and MBF is defined as myocar-
dial blood flow (in milliliters per 100 grams per minute).
For calculation of oxygen consumption at baseline and 4 and 24
hours after transplantation, total myocardial blood flow was de-
rived from regional myocardial blood flow, according to the ratio
of left ventricular/right ventricular/septal heart weight (0.65/0.25/
0.1). This ratio was determined by means of postmortem exami-
nations of the hearts. Of course, this method provides only an
approximate calculation of total myocardial blood flow.
Extraction of oxygen, glucose, and lactate was calculated by
using the following equation:
E 
A  V
A  100%, (3)
where E is defined as the extraction quotient (in percentage), A is
defined as the arterial substrate concentration, and V is defined as
the coronary sinus substrate concentration.
Myocardial Specific Enzymes
The routine test for assessment of creatine kinase MB (CK-MB)
does not produce reliable data in pigs.3 Therefore we used an
agarose electrophoresis test (REP-CK/LD-isoenzyme combo
method; Helena Laboratories, Beaumont, Tex). This test analyses
the percentage of CK-MB in relation to the total CK. Total CK was
measured photometrically with an enzymatic test (CK [NAC] AU
5000 Analyser System; Merck, Darmstadt, Germany).
Histologic Examinations
Specimens of the left midventricular wall were embedded in
paraffin and stained with hematoxylin-eosin and Luxol fast blue.
Luxol fast blue staining provides a safe identification of irrevers-
ibly damaged myocardium. Therefore the ratio of damaged myo-
cytes in relation to normal myocytes was assessed in 10 high-
power fields at 40-fold magnification by 2 blinded observers.
Statistical Analysis
Statistical analysis was performed with a statistical computer pro-
gram (Prism; Graph Pad Software, San Diego, Calif). Group
statistics were expressed as means  SD.
Two-group comparisons of the posttransplant values with the
baseline values, subendocardial versus subepicardial RMBF, and
left ventricle versus right ventricle were made by running a paired
t test with a 2-tailed P value. For analysis of repeated measures of
one variable, a repeated measures analysis of variance was used.
Intergroup comparisons were performed by using an unpaired t
test.
Results
Ischemic Time
Total ischemic time was 223  33 minutes in the control
group and 243  24 minutes in the NHBD group (not
significant). Cold ischemic time was 162  33 minutes in
the control group and 151 16 minutes in the NHBD group
(not significant).
Time for Weaning
All animals could be weaned from cardiopulmonary bypass
after 58  28 minutes in the control group and 74  18
minutes in the NHBD group (not significant).
Hemodynamics
Data on henodynamics are shown in Tables 1 and 2. He-
modynamics remained stable throughout the observation
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period of 24 hours. For inotropic support, 0.1 g  kg1 
min1 of epinephrine was given.
The baseline data and hemodynamic assessments after
transplantation are summarized in Table 1.
In both groups cardiac output and ejection fraction of
both ventricles after transplantation were significantly im-
paired compared with baseline values. Differences between
the groups after transplantation were not significant. Heart
rate, left atrial and central venous pressure, and systemic
vascular and pulmonary vascular resistance were signifi-
cantly increased after transplantation.
The dp/dtmax and dp/dtmin, left ventricular PRSW, and
left ventricular end-systolic elastance (Ees) were not signif-
icantly changed 24 hours after transplantation compared
with the baseline values (Table 2). In contrast, right ven-
tricular PRSW and Ees were significantly increased in both
groups.
Regional Myocardial Blood Flow
RMBF data are shown in Figure 1. Measurements at base-
line revealed homogeneous distribution of blood flow with-
out significant differences between the left ventricle, right
ventricle, and septum (Figure 1, A). After transplantation,
RMBF was significantly increased in both ventricles but not
in the septum (Figure 1, B). Myocardial blood flow in the
subendocardial layer was higher compared with that in the
subepicardial layer in both ventricles (Figure 1, C and D).
The subendothelial/subepicardial myocardial blood flow ra-
tio did not change significantly over the observation period.
Intergroup differences in RMBF were not significant.
Metabolic Parameters
Data on metabolic parameters are shown in Figures 2
through 5. Myocardial oxygen consumption 4 hours after
TABLE 1. Hemodynamic parameters at baseline and after heart transplantation
Control group (n  6) NHBD group (n  6)
Baseline 4 h 24 h Baseline 4 h 24 h
CO (L/min) 5.4 0.8 2.9 0.1* 2.6 0.3* 4.2 0.7† 2.3 0.4* 2.8 0.5*
HR (min1) 97 19 137 6* 162 15*‡ 86 15 157 12* 143 11*†
CVP (mm Hg) 2.6 1.8 7.4 1.9* 8.8 3.8* 5.7 4.1 9.5 6.6* 9.7 5.2*
LAP (mm Hg) 6.4 0.8 6.3 1.4 8.6 1.6* 6.7 0.8 6.8 1.0 8.8 1.6*
MAP (mm Hg) 82 22 88 16 94 14 88 17 92 12 103 16
PAP (mm Hg) 19 2 23 3 20 3 16 3 20 8 20 4
SVR
(dynes  s1  cm5)
1176 134 2223 254* 2622 306* 1568 176 2869 304*† 2666 326*
PVR
(dynes  s1  cm5)
191 38 439 57* 351 49* 177 32 459 95* 320 71*
Data are given as mean  SD. CO, Cardiac output; HR, heart rate; CVP, central venous pressure; LAP, left atrial pressure; MAP, mean arterial pressure;
PAP, mean pulmonary artery pressure; SVR, systemic vascular resistance; PVR, pulmonary vascular resistance.
*P  .05 versus baseline.
†P  .05, 4 hours versus 24 hours.
TABLE 2. Systolic and diastolic parameters and PRSW at baseline and 24 hours after transplantation, as measured by using
the conductance catheter technique
Control group NHBD group
Baseline 24 h Baseline 24 h
LV dp/dtmax (mm Hg/s) 1942 562 1800 452 1764 436 2340 751
LV dp/dtmin (mm Hg/s) 1875 539 1924 500 1986 531 2198 600
RV dp/dtmax (mm Hg/s) 533 111 494 134 609 200 802 412
RV dp/dtmin (mm Hg/s) 424 111 448 140 384 78 462 101
LV PRSW (erg  103/mL) 68.0 12.4 73.5 16.1 64.3 10.1 66.5 11.3
RV PRSW (erg  103/mL) 10.0 3.8 21.8 5.2* 11.8 3.3 20.9 6.0*
LV EF (%) 54.5 5.2 27.5 7.7* 54.7 5.8 37.2 8.6*
RV EF (%) 59.5 6.2 32.3 8.3* 53.2 9.2 32.5 6.8*
LV Ees (mm Hg/mL) 3.4 0.8 3.3 0.9 3.3 0.5 3.1 0.6
RV Ees(mm Hg/mL) 0.35 0.08 1.05 0.29* 0.38 0.12 1.17 0.24*
LV, Left ventricle; RV, right ventricle; dp/dtmax and dp/dtmin, maximum and minimum of first derivative of pressure; EF, ejection fraction.
*P  .05 versus baseline.
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transplantation was slightly increased compared with base-
line values in both groups, but the difference was not
significant (Figure 2, A). After 24 hours, oxygen consump-
tion had completely normalized. Intergroup differences
were not significant. In the NHBD group oxygen extraction
was significantly decreased compared with that seen in the
control group 5, 20, 30, and 60 minutes after the start of
reperfusion. Thereafter, intergroup differences were not sig-
nificant (Figure 2, B).
Because of the substrate enrichment of blood cardioplegia,
glucose levels in the arterial blood were significantly increased
in the experimental group compared with in the control group
within the first 60 minutes after transplantation (Figure 3). In
both groups systemic glucose levels remained increased over
24 hours. At baseline, no arteriovenous difference of blood
glucose levels could be measured. Within the first 10 minutes
after the start of reperfusion, arteriovenous glucose extraction
reached negative values in the NHBD group but not in the
control group. After 24 hours, glucose extraction was 3.4% in
the control group and 2.4% in the experimental group. Inter-
group differences were significant 1 and 5 minutes after the
start of reperfusion.
Systemic lactate levels were significantly higher in the
experimental group within the first 60 minutes after the
start of reperfusion (Figure 4). In the control group
myocardial lactate production could be observed within
the first 20 minutes after aortic unclamping. In contrast,
the hearts of the NHBD group were able to consume
lactate. Intergroup differences were significant during the
first 10 minutes only.
Metabolic activity during controlled reperfusions of the
donor heart in the NHBD group is shown in Figure 5.
Starting the controlled reperfusion in the donor after 30
minutes of normothermic ischemia at a myocardial temper-
ature of 28°C, oxygen extraction reached greater than 70%,
indicating good metabolic activity. At the end of this first
reperfusion, myocardial temperature had decreased to 13°C
before the heart was excised and stored in ice-cold solution.
Figure 1. A, RMBF of the donor heart under resting conditions before organ procurement. There were no significant
differences between the left ventricle, right ventricle, and septum. There were also no significant intergroup
differences. B, RMBF 4 and 24 hours after transplantation in percentage of baseline value. There was a significant
increase of RMBF in the left and right ventricle but not in the septum. There were no significant intergroup
differences. *P < .05 versus baseline. C, Ratio of subendothelial/subepicardial myocardial blood flow (endo/epi
ratio) in the left ventricle. There was a slight but not significant decrease of subendothelial/subepicardial
myocardial blood flow ratio after 4 and 24 hours in both groups. D, Ratio of subendothelial/subepicardial
myocardial blood flow (endo/epi ratio) in the right ventricle. There were no significant changes in both groups.
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Reperfusion in the recipient was started after completion
of the first anastomosis at a temperature of 15°C. Temper-
ature was stepwise increased to 20°C. Oxygen extraction
ranged between 65% and 75%.
Myocardial Specific CK-MB
Myocardial specific CK-MD data are given in Figure 6.
CK-MB was significantly increased 30 minutes to 24 hours
after transplantation in both groups. The CK-MB level
Figure 3. Transmyocardial glucose extraction before and after heart transplantation. †P < .05, NHBD group versus
control group. There were increased arterial glucose levels in the NHBD group during the first hour of reperfusion.
There was glucose release from reperfused myocardium within the first 5 minutes after application of hot shot in
the experimental group. There were no intergroup differences between 2 and 24 hours after heart transplantation.
Figure 2. A, Myocardial oxygen consumption at baseline and after heart transplantation. There were no significant
changes of oxygen consumption after 4 and 24 hours and no intergroup differences. B, Myocardial oxygen
extraction before and after heart transplantation. †P < .05, NHBD group versus control group. Measurements were
performed before procurement of the donor heart (baseline) and after the start of reperfusion in the recipient
(control group, aortic unclamping; NHBD group, hot shot after completion of the last anastomosis). There was
decreased oxygen extraction in the experimental group during the first 60 minutes after the start of reperfusion.
There were no significant intergroup differences between 1 and 24 hours after heart transplantation.
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reached a peak after 2 hours and decreased 24 hours after
heart transplantation. Differences between the control and
NHBD groups were not significant.
Effectiveness of Leukocyte Filters
Data on the effectiveness of leukocyte filters are given in
Figure 7. Leukocyte counts proximal and distal to the leu-
kocyte filters were measured. Leukocyte filters removed
90% of leukocytes in the first 1000 mL of blood. After
filtration of 1500 and 2000 mL of blood, 88% and 53% of
leukocytes, respectively, were removed.
Histologic Examination
Data on histologic examination are given in Figure 8. Mi-
croscopic examination revealed no rejection of the trans-
planted heart. Only scattered ischemic damage (eg, slight
Figure 4. Transmyocardial lactate extraction before and after heart transplantation. †P < .05, NHBD group versus
control group. There were high lactate levels over 1 hour in the NHBD group. Lactate production in the control
group versus lactate consumption in the NHBD group during the first 20 minutes after start of reperfusion is shown.
Figure 5. Myocardial oxygen extraction and temperature during controlled reperfusions in the donor (after normothermic
ischemia) and in the recipient (after completion of the first anastomosis). There was high oxygen extraction at the start
of reperfusion after 30 minutes of normothermic ischemia, indicating viability of the myocardium.
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myocardial edema and leukocyte infiltration without myo-
cytolysis) could be found in the majority of specimens.
Differentiation of irreversibly damaged myocardium was
possible by means of Luxol fast blue staining. Examination
by 2 blinded observers revealed that only 2.6%  4.8% of
myocytes in the control group versus 1.8%  1.9% in the
NHBD group were damaged irreversibly.
Discussion
This experimental study shows that successful transplanta-
tion of hearts from NHBDs after 30 minutes of normother-
mic ischemia is possible without remarkable irreversible
damage and with equivalent recovery compared with that in
hearts harvested from heart-beating donors. For the first
time, comprehensive assessment of these hearts 24 hours
Figure 7. Extraction of leukocytes by leukocyte filters during controlled reperfusion. Flow rate was 200 to 300
mL/min. After 1000 mL of total blood volume, the filter becomes less functional.
Figure 6. Serum levels of CK-MB before and during the first 24 hours after heart transplantation. *P < .05 versus
baseline. The peak of CK-MB release was 2 to 8 hours after heart transplantation. There were no significant
intergroup differences.
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after transplantation has been performed. In summary, the
following results could be obtained:
1. There was no significant difference in contractility
between the NHBD group and the control group.
2. Regional myocardial blood flow was increased after
transplantation in both groups without intergroup dif-
ferences, indicating preserved function of the vascu-
lature and the endothelium.
3. In both groups there was no significant change in
myocardial oxygen consumption 24 hours after trans-
plantation compared with baseline values.
4. Myocardial specific CK and lactate dehydrogenase
levels of the experimental group did not differ signif-
icantly versus those of the control group.
5. Histologic examination showed only scattered irre-
versibly damaged myocardial cells in both groups.
Hemodynamics
Cardiac output and ejection fraction after transplantation
were significantly decreased compared with baseline values
in both groups (Table 1). This was associated with a dra-
matic increase in pulmonary vascular resistance, a common
problem after cardiopulmonary bypass in pigs.7 PRSW, Ees,
dp/dtmax, and dp/dtmin were not diminished after heart
transplantation, indicating normal contractile function (Ta-
ble 2).
In contrast, right ventricular, but not left ventricular,
PRSW and Ees were significantly increased. A possible
explanation of this phenomenon could be methodical prob-
lems related to the enormously increased afterload after
transplantation. Interpretation of pressure-volume loops
provides reliable assessment of contractility independent of
preload conditions, but results can be significantly influ-
enced by changing afterload conditions.8 An increase in
right ventricular PRSW index and Ees might result from the
enhanced afterload after transplantation and might not re-
flect an increase in myocardial contractility.
Regional Myocardial Blood Flow
Coronary blood flow was increased 4 and 24 hours after
transplantation in both groups (Figure 1). This enhancement
might be due to the application of epinephrine and has been
observed by other investigators.9,10 In contrast, ischemic
myocardial damage has been shown to be associated with
increased coronary resistance and restricted coronary flow
reserve.11,12 The finding of increased RMBF in the present
study shows no evidence of severe myocardial damage.
Figure 8. Groups of irreversibly damaged myocytes (1). (Luxol fast blue, original magnification 20.) In both groups
only a few focal lesions, including a maximum of 10 muscle cells, could be found.
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Metabolic Activity
Myocardial oxygen consumption of porcine myocardium at
rest (12 mL  kg1  min1) is comparable with that of
human hearts and reflects aerobic metabolism. Measure-
ments 4 and 24 hours after transplantation revealed no
significant changes in both groups (Figure 2). After 30
minutes of normothermic ischemia, myocardium was able
to extract 75% of oxygen from blood cardioplegia during
the first controlled reperfusion in the donor. Similar results
could be obtained after the start of reperfusion during im-
plantation of the donor heart (Figure 5).
Our data indicate full viability and preserved myocardial
function after transplantation of these ischemically compro-
mised hearts. Successful transplantation was possible by
using a new preservation strategy based on the concept of
integrated myocardial protection.13 Myocardial preservation
strategies must address a broad spectrum of pathophysio-
logic aspects. In addition to the established principles of
controlled reperfusion, further refinements have been used
to prevent leukocyte-mediated damage and preserve endo-
thelial function.
Leukocyte Depletion
Leukocyte filtration of blood cardioplegia has been shown
to reduce reperfusion damage in several experimental and
clinical studies.14-16 Leukocyte filters can remove more than
90% of blood leukocytes, but our data show that they
become less functional after blood delivery of greater than
1000 mL and have to be exchanged (Figure 7).
Adenosine
Damaged hearts exhibit loss of endothelium-dependant fac-
tors and reduced nitric oxide formation. Impairment of
endothelial function plays an important role in ischemia-
reperfusion injury and has been underestimated in previous
preservation strategies.17 We must consider endothelial
stunning and develop efforts to reduce this injury during
myocardial protection.18
Adenosine has been shown to have broad-spectrum car-
dioprotective effects by acting through multiple mecha-
nisms on neutrophils, endothelium, and myocytes.4,19
Berne20 described the key role of adenosine in the auto-
regulation of coronary blood flow. Furthermore, because of
stimulation of myocardial A1 receptors, adenosine activates
adenosine triphosphate–sensitive potassium channels and
attenuates myocardial stunning.21 Applied as an adjunct to
standard cold blood cardioplegia in hearts exposed to 30
minutes of normothermic ischemia, adenosine reversed the
postischemic systolic dysfunction.22
Intermittent Reperfusion During Donor Heart
Implantation
Another attempt to minimize myocardial damage in heart
transplantation is the application of blood cardioplegia dur-
ing implantation of the donor heart. We started antegrade
reperfusion with tepid blood cardioplegia (15°C) after com-
pletion of the first anastomosis to avoid the high tempera-
ture gradient between the reperfusate and the myocardium.
Blood cardioplegia was substrate enriched and supple-
mented with high doses of HOE 642 and adenosine. Various
modifications of early reperfusion with blood cardioplegia
have been described.23-25 Clinical investigations have
shown that intermittent cold blood cardioplegia during im-
plantation is superior to the conventional technique with
respect to the incidence of spontaneous defibrillation, return
to sinus rhythm, time of mechanical ventilation, and need
for inotropic support.23,24
Clinical Implications
The critical shortage of transplantable organs necessitates
the use of unconventional donors. Cautious liberalization of
donor criteria is justified. The use of NHBDs has been
proposed as one way to increase the donor pool for kidneys
and livers worldwide.26-29 Routine transplantation of islets
and lungs from NHBDs can be expected within the near
future.30,31 Isolated instances of clinical heart transplanta-
tion from NHBDs have been reported.32,33 The results are
encouraging and have increased the awareness of these
types of donors for organ procurement. The use of marginal
donors should be cautiously pursued as one way to help
alleviate the current shortage of donor organs.
As more experience in the use of NHBD is gathered, this
should serve as an impetus to further expand our knowledge
of biologic or physiologic alteration in these donors, which
can be minimized by newer technology. Refinements of the
preservation strategy are necessary to provide successful
transplantation of hearts from marginal donors or NHBDs.
Traditional myocardial protection techniques are sufficient
for good donor hearts and short ischemic times. Liberaliza-
tion of donor criteria requires broader use of controlled
reperfusion, leukocyte depletion, and other protective addi-
tives in heart transplantation.
Limitations of the Study
Increased afterload after heart transplantation, as indicated
by pulmonary and systemic vascular resistance, might in-
fluence contractility parameters (eg, cardiac output and
PRSW). Therefore comparison between hemodynamic
baseline data and posttransplant data bears problems. In
contrast, comparison between the NHBD group and the
control group is appropriate. Pharmacologic interventions to
decrease pulmonary vascular resistance would have been
helpful to avoid these problems and to adopt the model
more to the clinical setting.
NHBD hearts were obtained after arresting the hearts by
means of exsanguination. In the face of a potential clinical
setting with NHBDs (so-called controlled NHBDs), it has to
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be considered that donors are taken off the ventilator. There
is some evidence that death from asphyxia causes more
myocardial damage than death from exsanguination.34 Fur-
ther experiments are necessary with respect to the detrimen-
tal effects of anoxia and higher filling pressures to evaluate
the efficiency of our myocardial preservation strategy.
Moreover, the detrimental effects of brain death are not
considered in this experimental model. Possibly, brain death
of the donor could further impair the function of the trans-
planted hearts.
In conclusion, transplantation of ischemically compro-
mised hearts harvested after 30 minutes of normothermic
ischemia is possible in this experimental model without
relevant irreversible damage. Contractility, myocardial per-
fusion, metabolic activity, and histologic damage are com-
parable with those of hearts harvested from beating-heart
donors.
We acknowledge the statistical review by Mr Manfred Ol-
schewski, MSc, Institute of Medical Biometry of the Albert-
Ludwigs-University Freiburg.
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Discussion
Dr Frank W. Sellke (Boston, Mass). You had 2 groups of
animals, is that correct? One you harvested, the control group, and
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